Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes ...Middle East

Oversubscribed financing led by strategic investor, with participation from new and existing investors MINNEAPOLIS, June 25, 2024 /PRNewswire/ -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes, announced it has closed...

Hence then, the article about endogenex announces 88 million series c financing to complete pivotal trial of the recet system in patients with type 2 diabetes was published today ( Tuesday 25/06/2024 - 03:26 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes )

Also on site :

• Trump DOJ Refuses to Rule Out Second Amendment Right to Nuclear Weapons
• 53-year-old woman accused of stripping naked and assaulting customers in a Pennsylvania grocery store
• Is Europe heading to an energy crisis?